Neurocognitive assessments

BEHAVIORAL3 trials

Sponsors

University of Florida, Rachel Miller, University of California, San Diego

Conditions

Alcohol ConsumptionCarotid Artery DiseasesChemotherapy-induced Cognitive ImpairmentHIVMotivationNeurocognitive Dysfunction

Unknown Phase

ARCH II Study (Alcohol Research Center on HIV Study II)

CompletedNCT02563574

University of FloridaAlcohol Consumption, HIV, Motivation

Start: 2016-12-31End: 2021-12-16Updated: 2022-04-04

Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients

CompletedNCT03324945

Rachel MillerChemotherapy-induced Cognitive Impairment

Start: 2016-08-01End: 2019-04-01Updated: 2020-11-12

Assessing Neurocognition After Cerebrovascular Intervention

RecruitingNCT03344276

University of California, San DiegoCarotid Artery Diseases, Neurocognitive Dysfunction

Start: 2021-07-15End: 2025-12-31Target: 20Updated: 2025-02-06

Related Papers

Research and engagement considerations for alcohol use telehealth services within HIV care: a qualitative exploration in federally qualified health centers

AIDS Care2023-04-111 citations

Assessment of chemotherapy-induced cognitive impairment: A prospective study of the biochemical and metabolic effects of platinum/taxane-based chemotherapy in gynecologic cancer patients.

Journal of Clinical Oncology2021-05-20